Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epilepsy in autism.

Roberto Tuchman1, Isabelle Rapin

  • 1Miami Children's Hospital, Dan Marino Center, Department of Neurology, Weston, FL 33331, USA. tuchman@att.net

The Lancet. Neurology
|July 10, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Practice guideline: Treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Neurology·2020
Same author

Language regression in childhood.

Pediatric neurology·2020
Same author

Turning the tide on targeted treatments for neurodevelopmental disorders.

Neurology·2019
Same author

[Editorial. Neurodevelopment and autism].

Medicina·2019
Same author

What is the Relationship Between Autism Spectrum Disorders and Epilepsy?

Seminars in pediatric neurology·2017
Same author

Author response: The autism "epidemic": Ethical, legal, and social issues in a developmental spectrum disorder.

Neurology·2017
Same journal

Resolution of expression of concern-Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.

The Lancet. Neurology·2026
Same journal

UCL Queen Square Institute of Neurology: 75 years of innovation.

The Lancet. Neurology·2026
Same journal

Correction to Lancet Neurol 2026; 25: 631.

The Lancet. Neurology·2026
Same journal

Epstein-Barr virus and multiple sclerosis: from associations to mechanisms to potential therapies.

The Lancet. Neurology·2026
Same journal

Correction to Lancet Neurol 2025; 24: 740-52.

The Lancet. Neurology·2026
Same journal

Correction to Lancet Neurol 2026; 25: 357-67.

The Lancet. Neurology·2026
See all related articles

Autism spectrum disorder (ASD) carries an increased risk of epilepsy, influenced by age, cognitive function, and language deficits. Further research is needed for evidence-based treatments for individuals with ASD and epilepsy.

Area of Science:

  • Neurology
  • Developmental Neuroscience
  • Clinical Psychiatry

Background:

  • Autism spectrum disorder (ASD) is frequently associated with an increased risk of epilepsy.
  • The reported prevalence of epilepsy in individuals with ASD varies significantly across studies.
  • Factors such as age, cognitive abilities, and language impairments contribute to this variability.

Purpose of the Study:

  • To analyze the factors contributing to the variable prevalence of epilepsy in autism spectrum disorder.
  • To explore the potential shared genetic factors between autism and epilepsy.
  • To review the current understanding and research gaps regarding subclinical epilepsy in ASD.

Main Methods:

  • Systematic review of existing literature on epilepsy prevalence in autism.

Related Experiment Videos

  • Analysis of demographic and clinical factors associated with epilepsy in ASD cohorts.
  • Literature synthesis on the relationship between subclinical epilepsy, cognition, language, and behavior in ASD.

    • Main Results:

    • Epilepsy prevalence in ASD is highest in adolescents and young adults, those with moderate to severe intellectual disability, motor deficits, and severe receptive language impairments.
    • The co-occurrence of autism and epilepsy may suggest common underlying genetic factors in some individuals.
    • The impact of subclinical epilepsy on cognitive, language, and behavioral outcomes in ASD remains debated.

    Conclusions:

    • Age, cognitive level, and language disorder type are key determinants of epilepsy prevalence in autism.
    • The etiological link between autism and epilepsy warrants further investigation, particularly regarding shared genetic underpinnings.
    • There is a critical need for high-powered, double-blind studies to establish evidence-based treatment recommendations for individuals with autism, regression, and subclinical epilepsy.